Paul Buys Rotarix Royalties

Paul Capital Healthcare has purchased all royalties on worldwide sales of Rotarix, from the Cincinnati Children's Hospital Medical Center. No financial terms were disclosed. Rotarix is an oral vaccine developed to prevent rotavirus infection, a contagious viral disease that causes diarrhea and dehydration in infants and young children. Get more info.


Paul Capital Healthcare today announced that it has purchased a royalty interest in Rotarix